These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10648113)

  • 1. Stimulation of the developing immune system can prevent autoimmunity.
    Singh B
    J Autoimmun; 2000 Feb; 14(1):15-22. PubMed ID: 10648113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?
    Shoenfeld Y; Aron-Maor A
    J Autoimmun; 2000 Feb; 14(1):1-10. PubMed ID: 10648110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autism, viral infection and measles-mumps-rubella vaccination.
    Wakefield AJ; Montgomery SM
    Isr Med Assoc J; 1999 Nov; 1(3):183-7. PubMed ID: 10731332
    [No Abstract]   [Full Text] [Related]  

  • 4. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
    Amin J; Wong M
    Commun Dis Intell; 1999 Aug; 23(8):222. PubMed ID: 10497836
    [No Abstract]   [Full Text] [Related]  

  • 5. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ; Montgomery SM
    Adverse Drug React Toxicol Rev; 2000 Dec; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract]   [Full Text] [Related]  

  • 6. Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response.
    Halperin SA; McGrath P; Smith B; Houston T
    J Pediatr; 2000 Jun; 136(6):789-94. PubMed ID: 10839878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical safety issues of measles, mumps and rubella vaccines.
    Afzal MA; Minor PD; Schild GC
    Bull World Health Organ; 2000; 78(2):199-204. PubMed ID: 10743285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMR vaccination, Crohn's disease and autism: a real or imagined "stomach ache/headache?".
    Passwell JH
    Isr Med Assoc J; 1999 Nov; 1(3):176-7. PubMed ID: 10731330
    [No Abstract]   [Full Text] [Related]  

  • 10. Measles inclusion-body encephalitis caused by the vaccine strain of measles virus.
    Bitnun A; Shannon P; Durward A; Rota PA; Bellini WJ; Graham C; Wang E; Ford-Jones EL; Cox P; Becker L; Fearon M; Petric M; Tellier R
    Clin Infect Dis; 1999 Oct; 29(4):855-61. PubMed ID: 10589903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in the reactogenicity of measles-mumps-rubella vaccine.
    Shohat T; Green MS; Nakar O; Ballin A; Duvdevani P; Cohen A; Shohat M
    Isr Med Assoc J; 2000 Mar; 2(3):192-5. PubMed ID: 10774264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles, mumps, and rubella: prevention.
    Booy R; Sengupta N; Bedford H; Elliman D
    Clin Evid; 2006 Jun; (15):448-68. PubMed ID: 16973018
    [No Abstract]   [Full Text] [Related]  

  • 13. Who wouldn't protect children?
    Aston R
    Practitioner; 1998 Jul; 242(1588):503. PubMed ID: 10492926
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding autism.
    Cowley G
    Newsweek; 2000 Jul; 136(5):46-54. PubMed ID: 11009739
    [No Abstract]   [Full Text] [Related]  

  • 15. Infection and autoimmunity.
    Cooke A
    Blood Cells Mol Dis; 2009; 42(2):105-7. PubMed ID: 19027331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunisation and type 1 diabetes mellitus: is there a link?
    Hiltunen M; Lönnrot M; Hyöty H
    Drug Saf; 1999 Mar; 20(3):207-12. PubMed ID: 10221850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis following morbilli-parotitis-rubella vaccination.
    Dobrosavljevic D; Milinkovic MV; Nikolic MM
    J Eur Acad Dermatol Venereol; 1999 Jul; 13(1):59-61. PubMed ID: 10565633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polio vaccine and polio.
    Sepkowitz S
    Pediatrics; 1999 Mar; 103(3):694-5; author reply 695-6. PubMed ID: 10189298
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.